1
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Identifying gaps in the quality of latent tuberculosis infection care

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Latent tuberculosis infection (LTBI) occurs after transmission and acquisition of infection, when the tuberculosis (TB) bacteria lie dormant in a person. Nearly one-quarter of the world's population is estimated to have LTBI, yet few studies have been published assessing the quality of LTBI services globally. This paper reviews issues to providing patient-centered LTBI services and offers an example framework to formally assess the quality of LTBI patient care. By applying the LTBI cascade of care model, TB programmes can evaluate the gaps and barriers to high-quality care and develop locally-driven solutions to improve LTBI services. Quality care for LTBI must address some of the key challenges to services including: (1) low prioritization of LTBI; (2) gaps in healthcare provider knowledge about testing and treatment; and (3) patient concerns about side effects of preventive treatment regimens. TB programmes need to ensure that these issues are addressed in a patient-centered manner, with clear communication and ongoing evaluation of the quality of LTBI services. Quality LTBI care must be a central focus, particularly identifying and engaging more household contacts in preventive treatment, in order to halt the progression to active disease thereby stopping TB transmission globally.

          Related collections

          Most cited references25

          • Record: found
          • Abstract: found
          • Article: not found

          The cascade of care in diagnosis and treatment of latent tuberculosis infection: a systematic review and meta-analysis.

          WHO estimates that a third of the world's population has latent tuberculosis infection and that less than 5% of those infected are diagnosed and treated to prevent tuberculosis. We aimed to systematically review studies that report the steps from initial tuberculosis screening through to treatment for latent tuberculosis infection, which we call the latent tuberculosis cascade of care. We specifically aimed to assess the number of people lost at each stage of the cascade.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: found

            Prospects for tuberculosis elimination.

            The target for TB elimination is to reduce annual incidence to less than one case per million population by 2050. Meeting that target requires a 1,000-fold reduction in incidence in little more than 35 years. This can be achieved only by combining the effective treatment of active TB-early case detection and high cure rates to interrupt transmission-with methods to prevent new infections and to neutralize existing latent infections. Vigorous implementation of the WHO Stop TB Strategy is needed to achieve the former, facilitated by the effective supply of, and demand for, health services. The latter calls for new technology, including biomarkers of TB risk, diagnostics, drugs, and vaccines. An important milestone en route to elimination will be reached when there is less than 1 TB death per 100,000 population, marking entry into the elimination phase. This landmark can be reached by many countries within 1-2 decades.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: found

              Treatment of Latent Tuberculosis Infection : An Updated Network Meta-analysis

              Treatment of latent tuberculosis infection (LTBI) is an important component of tuberculosis (TB) control, and this study updates a previous network meta-analysis of the best LTBI treatment options to inform public health action and programmatic management of LTBI.
                Bookmark

                Author and article information

                Contributors
                Journal
                J Clin Tuberc Other Mycobact Dis
                J Clin Tuberc Other Mycobact Dis
                Journal of Clinical Tuberculosis and Other Mycobacterial Diseases
                Elsevier
                2405-5794
                05 January 2020
                February 2020
                05 January 2020
                : 18
                : 100142
                Affiliations
                [a ]Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Montreal, QC, Canada
                [b ]McGill International TB Centre, McGill University, 5252 Boulevaerd de Maisonneuve, Room 3D.58, Montreal, QC, Canada
                [c ]Respiratory Epidemiology and Clinical Research Unit (RECRU), McGill University, Montreal, QC, Canada
                Author notes
                [* ]Corresponding author at: Respiratory Epidemiology and Clinical Research Unit Montreal Chest Institute & McGill International TB Centre 5252 de Maisonneuve Blvd West, Room 3D.58 Montreal, QC Canada. dick.menzies@ 123456mcgill.ca
                Article
                S2405-5794(20)30001-2 100142
                10.1016/j.jctube.2020.100142
                6957813
                31956699
                72e7bc3b-24be-4b97-ae97-47584b1b74a9
                © 2020 Published by Elsevier Ltd.

                This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).

                History
                Categories
                Article

                latent tuberculosis infection,ltbi,quality care,cascade of care,preventive treatment

                Comments

                Comment on this article